Press "esc" to clear
Go to Advanced Search

Showing results

110 of 5982
Embargo will expire:
25-Oct-2018 11:00 AM EDT
Released to reporters:
18-Oct-2018 2:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 25-Oct-2018 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Maves_Farr_lab.jpg

Article ID: 702433

Tailor-Made Fish Help Explain Genetic Conditions in Children

Seattle Children's Hospital

At Seattle Children's Research Institute, scientists are genetically-engineering zebrafish to harbor human DNA mutations known to contribute congenital conditions in children.

Released:
18-Oct-2018 12:40 PM EDT
Embargo will expire:
23-Oct-2018 11:00 AM EDT
Released to reporters:
18-Oct-2018 11:30 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Oct-2018 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
25-Oct-2018 11:00 AM EDT
Released to reporters:
18-Oct-2018 11:05 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 25-Oct-2018 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

SkinCream.jpg
  • Embargo expired:
    18-Oct-2018 11:00 AM EDT

Article ID: 702275

Cancer Patients Can Now Use Skin Creams During Radiation Therapy

Perelman School of Medicine at the University of Pennsylvania

Contrary to the advice most cancer patients receive when they go through radiation treatment, topical skin treatments, unless applied very heavily, do not increase the radiation dose to the skin and can be used in moderation before daily radiation treatments.

Released:
16-Oct-2018 10:30 AM EDT
Cardinezetal.jpg
  • Embargo expired:
    18-Oct-2018 9:00 AM EDT

Article ID: 702172

Researchers Describe Novel Immune Syndrome

The Rockefeller University Press

Researchers from Australia and Japan have discovered a new human immunodeficiency syndrome in two patients on separate continents. The study, which will be published October 18 in the Journal of Experimental Medicine, reveals that a mutation in a gene called IKBKB disrupts the immune system, leading to excessive inflammation and the loss of both T and B white blood cells.

Released:
15-Oct-2018 9:45 AM EDT
drugsensitivity.jpg
  • Embargo expired:
    17-Oct-2018 1:00 PM EDT

Article ID: 702175

Vast Leukemia Dataset Could Help Researchers Match Therapies to Patients

Howard Hughes Medical Institute (HHMI)

Data on the molecular makeup and drug sensitivity of hundreds of patient samples could accelerate progress against the aggressive blood cancer acute myeloid leukemia.

Released:
15-Oct-2018 10:05 AM EDT
Tsai.jpg

Article ID: 702353

St. Jude Researcher Receives Share of $86 Million in NIH Funding

St. Jude Children's Research Hospital

Shengdar Tsai, Ph.D., an assistant member of the Department of Hematology at St. Jude Children’s Research Hospital, has received a five-year $3 million grant from the National Institutes of Health’s Common Fund for his work on genome editing safety.

Released:
17-Oct-2018 12:05 PM EDT

Article ID: 702338

Researcher Wins Breakthrough Prize for Innate Immunity Discovery

UT Southwestern Medical Center

UT Southwestern biochemist Dr. Zhijian “James” Chen today was named winner of the prestigious 2019 Breakthrough Prize in Life Sciences for his discovery of the cGAS enzyme that launches the body’s immune defense against infections and cancers. That enzyme patrols the cell’s interior and triggers the immune system in response to DNA.

Released:
17-Oct-2018 10:05 AM EDT
DOE-bioprivileged1.JPG

Article ID: 702320

Researchers Develop, Test New System for Making Biorenewable Chemicals

Iowa State University

The U.S. Department of Energy is supporting development of a system for producing biobased chemicals that's based on the idea of "bioprivileged molecules." Researchers at the Center for Biorenewable Chemicals based at Iowa State University say such molecules have new and valuable properties.

Released:
16-Oct-2018 4:55 PM EDT

Showing results

110 of 5982

Chat now!